Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

BG Medicine Announces FDA Clearance of its Galectin-3 Test for Use in Patients with...


BG Medicine, Inc., a U.S.-based life sciences company, announced that the U.S. FDA has cleared...

NanoString Launches First Simple and Precise Approach to Detect Hundreds of Genetic Copy Variants...


NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting...

Merrion Pharmaceuticals Plc announces commencement of feasibility and option agreement with Rebel Pharmaceuticals


Merrion Pharmaceuticals Plc, a publicly listed product development company, announced the commencement of an oral...

Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment...


Abbott announced positive results from a Phase 2 dose-ranging study of atrasentan, a highly selective...

Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl


Reata Pharmaceuticals and Abbott announced data from a Phase 2b study which suggests that bardoxolone...

Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment


Novartis presented today a strategic overview of the company's diversified healthcare portfolio which creates the...

Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships


Pfizer Inc. announced the establishment of the Global Centers for Therapeutic Innovation, an entrepreneurial...

Pfizer Inc, Study Shows Adding INSPRA to Standard Therapy Significantly Reduces the Risk of...


Pfizer Inc. announced results from the EMPHASIS-HF trial(1) showing a statistically significant reduction in risk...

Forest Laboratories Enters Collaboration on Bystolic(R) and Savella(R)


Forest Laboratories, Inc. announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered...

Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory Committee Meeting to Discuss New...


  Endo Pharmaceuticals announced that the U.S. FDA has informed the company that FDA no...